Expanded funding of SPINRAZA for treatment of pre-symptomatic SMA babies

“Biogen has been, and continues to be, committed to working with all stakeholders to ensure SPINRAZA is available as an option for people with SMA to treat this devastating disease,” said David Henderson, the managing director of Biogen Australia and New Zealand. …